NFA
MYGN icon

Nationwide Fund Advisors’s Myriad Genetics MYGN Stock Holding History

Nationwide Fund Advisors’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-92,891
Closed -$3.36M – 1329
2017
Q3 		$3.36M Buy
92,891
+213
+0.2% +$6.08K 0.01% 1199
2017
Q2 		$2.4M Buy
92,678
+50,025
+117% +$1.06M 0.01% 1347
2017
Q1 		$819K Sell
42,653
-2,938
-6% -$52.1K ﹤0.01% 1874
2016
Q4 		$760K Buy
45,591
+1,376
+3% +$24.9K ﹤0.01% 1934
2016
Q3 		$910K Hold
44,215
– – ﹤0.01% 1846
2016
Q2 		$1.35M Sell
44,215
-802
-2% -$27.9K 0.01% 1558
2016
Q1 		$1.71M Sell
45,017
-555
-1% -$20.9K 0.01% 1424
2015
Q4 		$1.97M Buy
45,572
+896
+2% +$37.9K 0.01% 1368
2015
Q3 		$1.67M Sell
44,676
-162
-0.4% -$5.75K 0.01% 1468
2015
Q2 		$1.52M Buy
+44,838
New +$1.52M 0.01% 1602

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nationwide Fund Advisors's MYGN Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Myriad Genetics (MYGN) in Q4 2017, closing a stake of 92,891 shares — an estimated $3.36M sold.

Nationwide Fund Advisors first reported a position in MYGN in Q2 2015 and held it in 10 quarters. The position peaked at $3.36M in Q3 2017. 250 funds tracked by Wall St. Rank hold MYGN as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Myriad Genetics position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 92,891 Myriad Genetics shares in Q4 2017, an estimated $3.36M.
  • Nationwide Fund Advisors first reported a position in Myriad Genetics in Q2 2015 and held it in 10 quarters.
  • Nationwide Fund Advisors's Myriad Genetics position peaked at $3.36M in Q3 2017.
  • 250 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.